Table 4.
Association of asymptomatic cardiovascular impairments with individual components of MS.
| Variables | LVH | LV diastolic dysfunction | Arteriosclerosis | Microalbuminuria | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 1 | Model 2 | Model 1 | Model 2 | Model 1 | Model 2 | |||||||||
| OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
| Central obesity | 1.866 (1.451–2.400) | <0.001 | 1.750 (1.354–2.262) | <0.001 | 1.730 (1.230–2.433) | 0.002 | 1.543 (1.091–2.182) | 0.014 | 1.751 (1.234–2.483) | 0.002 | 1.468 (1.025–2.102) | 0.036 | 1.393 (1.151–1.687) | 0.001 | 1.257 (1.032–1.532) | 0.031 |
| High BP | 1.734 (1.310–2.294) | <0.001 | 1.577 (1.185–2.099) | 0.002 | 1.968 (1.320–2.935) | 0.001 | 1.744 (1.162–2.617) | 0.007 | 3.241 (1.953–5.379) | <0.001 | 2.853 (1.702–4.783) | <0.001 | 1.490 (1.210-−1.835) | <0.001 | 1.340 (1.082–1.661) | 0.007 |
| Elevated PG | 1.158 (0.917–1.462) | 0.217 | 1.055 (0.830–1.340) | 0.661 | 1.453 (1.073–1.969) | 0.016 | 1.306 (0.957–1.783) | 0.092 | 2.711 (1.965–3.741) | <0.001 | 2.561 (1.838–3.569) | <0.001 | 1.524 (1.261–1.842) | <0.001 | 1.419 (1.169–1.722) | <0.001 |
| High TG | 1.096 (0.869–1.383) | 0.4401 | 1.023 (0.781–1.340) | 0.867 | 1.463 (1.078–1.987) | 0.015 | 1.414 (0.994–2.012) | 0.054 | 1.345 (0.974–1.855) | 0.072 | 1.289 (0.892–1.863) | 0.177 | 1.351 (1.120–1.630) | 0.002 | 1.293 (1.040–1.608) | 0.021 |
| Low HDL-c | 1.048 (0.828–1.327) | 0.697 | 0.949 (0.722–1.248) | 0.710 | 1.115 (0.818–1.520) | 0.490 | 0.853 (0.597–1.219) | 0.382 | 0.909 (0.649–1.274) | 0.579 | 0.685 (0.467–1.018) | 0.063 | 1.130 (0.933–1.368) | 0.212 | 0.913 (0.731–1.141) | 0.425 |
The ORs and 95% CI were calculated to estimate the associations of various cardiovascular impairments with individual components of MS by using binary logistic regression models. Model 1 was adjusted for age, sex, serum creatinine, serum uric acid, smoking status, and family history of premature CVD. Model 2 was further adjusted for the other four MS components simultaneously.
BP, blood pressure; CI, confidence interval; CVD, cardiovascular diseases; HDL-c, high-density lipoprotein cholesterol; LV, left ventricle; LVH, left ventricle hypertrophy; MS, metabolic syndrome; OR, odds ratio; PG, plasma glucose; TG, triglyceride.